Compare PTY & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTY | ITGR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2002 | 2000 |
| Metric | PTY | ITGR |
|---|---|---|
| Price | $11.66 | $90.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $91.14 |
| AVG Volume (30 Days) | ★ 1.0M | 578.3K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.48 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | N/A | $6.53 |
| P/E Ratio | ★ N/A | $188.40 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $11.58 | $62.00 |
| 52 Week High | $14.69 | $123.78 |
| Indicator | PTY | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 24.84 | 58.17 |
| Support Level | N/A | $82.58 |
| Resistance Level | $13.17 | $108.99 |
| Average True Range (ATR) | 0.10 | 3.88 |
| MACD | -0.06 | 0.47 |
| Stochastic Oscillator | 0.70 | 92.71 |
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.